Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Are tolerance and training required to end TB?

Nature Reviews Immunology volume 18, pages 661–663 (2018)Cite this article

Subjects

Host defence strategies against Mycobacterium tuberculosis (Mtb), the bacterium that causes tuberculosis (TB), include host resistance and disease tolerance. To date, most studies have focused on resistance mechanisms, but developing new strategies to eradicate Mtb will require an understanding of the entire landscape of immunity in TB. Here I discuss two evolutionarily conserved host defence strategies, disease tolerance and trained immunity (memory-like innate immune responses), and their role in Mtb infection.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Nuts and bolts of trained immunity.

References

  1. Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).

    Article  Google Scholar 

  2. Pai, M. et al. Tuberculosis. Nat. Rev. Dis. Primers 2, 16076 (2016).

    Article  Google Scholar 

  3. Nunes-Alves, C. et al. In search of a new paradigm for protective immunity to TB. Nat. Rev. Microbiol. 12, 289–299 (2014).

    Article  CAS  Google Scholar 

  4. Mishra, B. B. et al. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat. Microbiol. 2, 17072 (2017).

    Article  CAS  Google Scholar 

  5. Gieseck, R. L. 3rd, Wilson, M. S. & Wynn, T. A. Type 2 immunity in tissue repair and fibrosis. Nat. Rev. Immunol. 18, 62–76 (2018).

    Article  CAS  Google Scholar 

  6. Cadena, A. M., Fortune, S. M. & Flynn, J. L. Heterogeneity in tuberculosis. Nat. Rev. Immunol. 17, 691–702 (2017).

    Article  CAS  Google Scholar 

  7. Nemes, E. et al. Prevention of M. tuberculosis infection with H4:IC31 vaccine or BCG revaccination. N. Engl. J. Med. 379, 138–149 (2018).

    Article  CAS  Google Scholar 

  8. Tzelepis, F. et al. Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to tuberculosis. Sci. Immunol. 3, eaar4135 (2018).

    Article  Google Scholar 

  9. Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176–190 (2018).

    Article  CAS  Google Scholar 

  10. Fleming-Davies, A. E. et al. Incomplete host immunity favors the evolution of virulence in an emergent pathogen. Science 359, 1030–1033 (2018).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Canadian Institute of Health Research (CIHR) Foundation Grant (FDN-143273) to M.D. and M.D. holds a Fonds de la Recherche du Quebec- Sante (FRQS) Award and the Strauss Chair in Respiratory Diseases.

Author information

Authors and Affiliations

  1. Departments of Medicine, Microbiology and Immunology, and Pathology, Meakins-Christie Laboratories, McGill International TB Centre and McGill University Health Centre, McGill University, Montreal, Québec, Canada

    Maziar Divangahi

Authors
  1. Maziar Divangahi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maziar Divangahi.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Divangahi, M. Are tolerance and training required to end TB?. Nat Rev Immunol 18, 661–663 (2018). https://doi.org/10.1038/s41577-018-0070-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41577-018-0070-y

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing